Search results for 4-1BB

Brilliant Violet 785™ anti-human CD137 (4-1BB) Antibody, CD137, S18014C, BioLegend, 300818

Ultra-LEAF™ Purified anti-human CD137 (4-1BB) antibody, CD137, W18063F, BioLegend, 944903

Ultra-LEAF™ Purified anti-human CD137 (4-1BB) antibody, CD137, W18063F, BioLegend, 944904

Research Grade Anti-4-1BB & TPBG/5t4 Bispecific Antibody (Apv-527) (HC336206), abinScience, HC336206

APC/Cyanine7 anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309829

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

APC/Cyanine7 anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309830

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

PE/Cyanine5 anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309808

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

PerCP/Cyanine5.5 anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309813

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

PerCP/Cyanine5.5 anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309814

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

PE/Cyanine7 anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309817

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).